Dr Martens says upcoming season is crucial after 9% drop in half-year revenue
Dr Martens reported a 9.2% fall in constant-currency revenue for the first half and warned that the full-year result hinges on trading in the coming season.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
British bootmaker Dr Martens said on Thursday that first-half revenue fell 9.2% in constant currency, to £290.4 million ($384.98 million) in the six months to September 27. Sales were weaker in the second quarter than in the first, and the drop in the UK was bigger than expected.
The company said trading in the key season ahead will be crucial to its full-year result and left a wide range of possible outcomes for both sales and profit. CEO Ije Nwokorie called the half-year performance "disappointing", saying weakness in boots was not offset by demand for shoes and sandals.
why it matters
For markets, the key question is not the half-year figures themselves but how the coming season goes. A wide range of outcomes adds uncertainty for a brand that relies heavily on boot demand, and such warnings often weigh on a company's valuation more than past quarterly numbers.
market impact
Dr Martens shares: weak boot demand and an uncertain outlook pressure the stock
- Dr Martens shares pressure down — weak sales and an uncertain outlook for the key season
tags
instruments
sources
- Dr Martens warns trading in season ahead crucial after 9% half-year revenue drop — Reuters, 12 November 2026 at 07:12 UTC
- Bootmaker Dr Martens warns trading in season ahead crucial after 9% half-year revenue drop — Reuters, 12 November 2026 at 07:24 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗